Fabrication and comprehensive evaluation of Zr-based bulk metallic glass matrix composites for biomedical applications

Abstract The aim of this study is to fabricate Zr-based bulk metallic glass matrix composites (BMG-MCs) for biomedical usage and subject them to a comprehensive and farreaching analysis with respect to their mechanical properties, biocorrosion resistance, biocompatibility, and interactions with biofilms that all may arise from their chemical compositions and unusual disordered internal structure. In this study, we fabricate Zr 40 Ti 15 Cu 10 Ni 10 Be 25 , Zr 50 Ti 15 Cu 10 Ni 10 Be 25 , and Zr 40 Ti 15 Cu 10 Ni 5 Si 5 Be 25 alloys and confirm their glassy matrix nature through differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) analyses. The mechanical properties, assessed via nanoindentation, demonstrate the high hardness, strength, and elasticity of the produced materials. Corrosion resistance is investigated in simulated body fluid, with Zr-based BMG-MCs exhibiting superior performance compared to conventional biomedical materials, including 316L stainless steel and Ti6Al4V alloy. Biocompatibility is assessed using human fetal osteoblastic cell line hFOB 1.19, revealing low levels of cytotoxicity. The study also examines the potential for biofilm formation, a critical factor in the success of biomedical implantation, where bacterial infection is a major concern. Our findings suggest, as never reported before, that Zr-based BMG-MCs, with their unique composite glassy structure and excellent physicochemical properties, are promising candidates for various biomedical applications, potentially offering improved performance over traditional metallic biomaterials.